Diabetes, Obesity and Metabolism Vol 12 Iss 3 2010

REVIEW ARTICLES

p179-185
Oral insulin – a review of current status
Harish Iyer et al.
Abstract
Published Online: 22 Sep 2009

p186-194
Benefits of moderate weight loss in patients with type 2 diabetes
Ken Fujioka
Abstract
Published Online: 22 Sep 2009

ORIGINAL ARTICLES

p195-203
Selective effects of PPARγ agonists and antagonists on human pre-adipocyte differentiation
C. Leyvraz et al.
Abstract
Published Online: 5 Nov 2009

p204-209
A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study
A. Elhayany et al.
Abstract
Published Online: 22 Sep 2009

p210-218
Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither
S. Conard et al.
Abstract
Published Online: 22 Sep 2009

p219-223
Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects
R. Eldor et al.
Abstract
Published Online: 22 Sep 2009

p224-233
Combination treatment with alogliptin and voglibose increases active GLP-1 circulation, prevents the development of diabetes and preserves pancreatic beta-cells in prediabetic db/db mice
Y. Moritoh et al.
Abstract
Published Online: 22 Sep 2009

p234-245
Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice
M. Perreault et al.
Abstract
Published Online: 22 Sep 2009

p246-251
Colestilan monotherapy significantly improves glycaemic control and LDL cholesterol levels in patients with type 2 diabetes: a randomized double-blind placebo-controlled study
K. Kondo, T. Kadowaki
Abstract
Published Online: 22 Sep 2009

p252-261
Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
P. Aschner et al.
Abstract
Published Online: 25 Nov 2009